Fang, Z.; Wang, W.; Liu, Y.; Hua, J.; Liang, C.; Liu, J.; Zhang, B.; Shi, S.; Yu, X.; Meng, Q.;
et al. Cuproptosis-Related Gene DLAT as a Novel Biomarker Correlated with Prognosis, Chemoresistance, and Immune Infiltration in Pancreatic Adenocarcinoma: A Preliminary Study Based on Bioinformatics Analysis. Curr. Oncol. 2023, 30, 2997-3019.
https://doi.org/10.3390/curroncol30030228
AMA Style
Fang Z, Wang W, Liu Y, Hua J, Liang C, Liu J, Zhang B, Shi S, Yu X, Meng Q,
et al. Cuproptosis-Related Gene DLAT as a Novel Biomarker Correlated with Prognosis, Chemoresistance, and Immune Infiltration in Pancreatic Adenocarcinoma: A Preliminary Study Based on Bioinformatics Analysis. Current Oncology. 2023; 30(3):2997-3019.
https://doi.org/10.3390/curroncol30030228
Chicago/Turabian Style
Fang, Zengli, Wei Wang, Yuan Liu, Jie Hua, Chen Liang, Jiang Liu, Bo Zhang, Si Shi, Xianjun Yu, Qingcai Meng,
and et al. 2023. "Cuproptosis-Related Gene DLAT as a Novel Biomarker Correlated with Prognosis, Chemoresistance, and Immune Infiltration in Pancreatic Adenocarcinoma: A Preliminary Study Based on Bioinformatics Analysis" Current Oncology 30, no. 3: 2997-3019.
https://doi.org/10.3390/curroncol30030228
APA Style
Fang, Z., Wang, W., Liu, Y., Hua, J., Liang, C., Liu, J., Zhang, B., Shi, S., Yu, X., Meng, Q., & Xu, J.
(2023). Cuproptosis-Related Gene DLAT as a Novel Biomarker Correlated with Prognosis, Chemoresistance, and Immune Infiltration in Pancreatic Adenocarcinoma: A Preliminary Study Based on Bioinformatics Analysis. Current Oncology, 30(3), 2997-3019.
https://doi.org/10.3390/curroncol30030228
